Undefeated-Changing the phenamacril scaffold is not enough to beat resistant Fusarium.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32598376.
- Also identified by DOI 10.1371/journal.pone.0235568 and PMC identifier 7323951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Filamentous fungi belonging to the genus Fusarium are notorious plant-pathogens that infect, damage and contaminate a wide variety of important crops. Phenamacril is the first member of a novel class of single-site acting cyanoacrylate fungicides which has proven highly effective against important members of the genus Fusarium. However, the recent emergence of field-resistant strains exhibiting qualitative resistance poses a major obstacle for the continued use of phenamacril. In this study, we synthesized novel cyanoacrylate compounds based on the phenamacril-scaffold to test their growth-inhibitory potential against wild-type Fusarium and phenamacril-resistant strains. Our findings show that most chemical modifications to the phenamacril-scaffold are associated with almost complete loss of fungicidal activity and in vitro inhibition of myosin motor domain ATPase activity.
Medical subject headings
- Cyanoacrylates
- Drug Resistance, Fungal
- Fungicides, Industrial
- Fusarium